These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1117 related articles for article (PubMed ID: 11827836)

  • 1. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
    Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
    Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals.
    Rizzieri DA; Liu J; Miralles D; Traweek ST
    Cancer J Sci Am; 1997; 3(3):153-6. PubMed ID: 9161780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HHV-8 DNA in blood and the development of HIV-associated Kaposi's sarcoma in the era of HAART--a prospective evaluation.
    Lorenzen T; Albrecht D; Paech V; Meyer T; Hoffmann C; Stoehr A; Degen O; Stellbrink HJ; Meigel WN; Arndt R; Plettenberg A
    Eur J Med Res; 2002 Jun; 7(6):283-6. PubMed ID: 12117665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
    Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
    Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
    J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus.
    Gnann JW; Pellett PE; Jaffe HW
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S72-6. PubMed ID: 10770915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
    Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions.
    Bryant-Greenwood P; Sorbara L; Filie AC; Little R; Yarchoan R; Wilson W; Raffeld M; Abati A
    Mod Pathol; 2003 Feb; 16(2):145-53. PubMed ID: 12591967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
    Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
    Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
    Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
    AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients.
    Chandra A; Demirhan I; Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Linde A; Heiden T; Biberfeld P; Doerr HW; Cinatl J; Loewer J; Chandra P
    Anticancer Res; 2003; 23(1B):723-8. PubMed ID: 12680174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
    Inoue N; Spira T; Lam L; Corchero JL; Luo W
    J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
    Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B
    Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
    Bihl F; Berger C; Chisholm JV; Henry LM; Bertisch B; Trojan A; Nadal D; Speck RF; Flepp M; Brander C; Mueller NJ;
    AIDS; 2009 Sep; 23(14):1918-22. PubMed ID: 19609199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult lymphadenopathic Kaposi's sarcoma associated with severe pulmonary hypertension: A clinical hint about the potential role of HHV-8 in HIV-related pulmonary hypertension?
    Gutiérrez F; Masiá M; Padilla S; Ramos JM; Bernal E; Morales P; Pozo F; Andrada E; Martin-Hidalgo A
    J Clin Virol; 2006 Oct; 37(2):79-82. PubMed ID: 16884948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
    Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
    Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.
    Jacobson LP; Jenkins FJ; Springer G; Muñoz A; Shah KV; Phair J; Zhang Z; Armenian H
    J Infect Dis; 2000 Jun; 181(6):1940-9. PubMed ID: 10837173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.